agilon health, inc. (NYSE:AGL) Short Interest Update

agilon health, inc. (NYSE:AGL) was the target of a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 29,790,000 shares, a decline of 6.7% from the November 30th total of 31,940,000 shares. Currently, 9.8% of the company’s shares are sold short. Based on an average daily volume of 4,350,000 shares, the days-to-cover ratio is currently 6.8 days.

Insider Transactions at agilon health

In other agilon health news, Director Diana Mckenzie purchased 12,500 shares of agilon health stock in a transaction on Monday, November 25th. The shares were purchased at an average cost of $2.28 per share, with a total value of $28,500.00. Following the completion of the transaction, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. This represents a 32.20 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Karen Mcloughlin acquired 25,000 shares of the firm’s stock in a transaction on Friday, December 13th. The shares were acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now owns 73,166 shares of the company’s stock, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders bought 90,000 shares of company stock worth $198,100. 3.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On agilon health

Several institutional investors have recently made changes to their positions in AGL. State Street Corp boosted its position in agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares during the period. Geode Capital Management LLC lifted its stake in agilon health by 1.2% in the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after buying an additional 84,889 shares during the last quarter. Citigroup Inc. boosted its holdings in shares of agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the period. JPMorgan Chase & Co. grew its position in shares of agilon health by 326.4% during the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock worth $5,563,000 after acquiring an additional 1,083,492 shares during the last quarter. Finally, AQR Capital Management LLC increased its holdings in shares of agilon health by 3,338.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares during the period.

Analyst Upgrades and Downgrades

A number of research analysts have commented on AGL shares. Citigroup reduced their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research note on Wednesday, November 13th. William Blair cut agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Sanford C. Bernstein started coverage on shares of agilon health in a research note on Wednesday, December 11th. They set a “market perform” rating and a $2.50 price objective on the stock. Macquarie began coverage on shares of agilon health in a research note on Monday, December 16th. They issued a “neutral” rating and a $3.00 target price for the company. Finally, Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a research note on Wednesday, October 2nd. Three research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $4.28.

agilon health Stock Performance

agilon health stock opened at $1.90 on Thursday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health has a 12 month low of $1.50 and a 12 month high of $13.28. The company has a fifty day moving average price of $2.14 and a two-hundred day moving average price of $3.98. The company has a market cap of $782.83 million, a PE ratio of -2.02 and a beta of 0.51.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period last year, the firm posted ($0.06) earnings per share. Research analysts expect that agilon health will post -0.52 earnings per share for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.